ExamWorks Group, Inc. (NYSE:EXAM) reported Revenues for the fourth quarter of 2015 were $208.5 million, an increase of $6.4 million, or 3.2%, over the year-ago quarter revenues of $202.1 million. On a constant currency basis, revenues increased 6.9% with organically generated revenues increasing 2.4% during the fourth quarter of 2015. Currency headwinds negatively impacted reported revenues this quarter by approximately $7.6 million when compared to the prior year quarter.
ExamWorks Group, Inc. (NYSE:EXAM) belongs to Financial sector. Its net profit margin is 0.60% and weekly performance is 11.63%. On last trading day company shares ended up at $28.60. ExamWorks Group, Inc. (NYSE:EXAM) distance from 50-day simple moving average (SMA50) is 8.33%.
Peak Resorts Inc (NASDAQ:SKIS) was downgraded by Macquarie from a “neutral” rating to an “underperform” rating in a note issued to investors on Thursday, The Fly reports.
Peak Resorts, Inc. (NASDAQ:SKIS) shares moved down -10.35% in last trading session and ended the day at $3.81. SKIS return on assets is -0.40%. Peak Resorts, Inc. (NASDAQ:SKIS) quarterly performance is -43.26%.
Ur-Energy Inc. (NYSE MKT:URG) announces that it will host a webcast and teleconference on March 2, 2016 to discuss the Company’s year-end results, following the filing of its Annual Report on Form 10-K, which it anticipates filing on February 26, 2016.
On 24 February, UR-Energy Inc. (NYSEMKT:URG) shares moved down -2.53% and was closed at $0.48. URG EPS growth in last 5 year was 18.90%. UR-Energy Inc. (NYSEMKT:URG) year to date (YTD) performance is -25.77%.
Compass Minerals International Inc. (NYSE:CMP) board of directors has approved a 5 percent increase in the company’s quarterly dividend to $0.695 per share, effective with its dividend payable March 15, 2016, to shareholders of record as of the close of business on Feb. 29, 2016.
Compass Minerals International Inc. (NYSE:CMP) ended the last trading day at $68.44. Company weekly volatility is calculated as 2.55% and price to cash ratio as 39.49. Compass Minerals International Inc. (NYSE:CMP) showed a weekly performance of -1.14%.
On 18 February, Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) reported Collaboration revenue was $59.1 million for the year ended December 31, 2015, compared to $65.4 million for the prior year. Beginning in the first quarter of 2015, the company began offsetting research and development expense for amounts received from Celgene for reimbursement of certain development costs incurred on Celgene’s behalf related to AG-221 which were presented as gross collaboration revenue during 2014.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) shares moved up 0.31% in last trading session and ended the day at $38.32. AGIO return on assets is -22.00%. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) quarterly performance is -38.66%.